These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The plasma gelsolin levels in atopic dermatitis: Effect of atopy and disease severity. Eke Gungor H, Sahiner UM, Karakukcu C, Sahiner N, Altuner Torun Y. Allergol Immunopathol (Madr); 2016; 44(3):221-5. PubMed ID: 26318415 [Abstract] [Full Text] [Related]
4. Factors that predict disease severity in atopic dermatitis: The role of serum basal tryptase. Sahiner UM, Buyuktiryaki B, Gungor HE, Sahiner N, Turasan A, Torun YA, Sekerel BE. Allergy Asthma Proc; 2018 Sep 01; 39(5):371-376. PubMed ID: 30153887 [Abstract] [Full Text] [Related]
10. Development of atopic dermatitis during the first 3 years of life: the Copenhagen prospective study on asthma in childhood cohort study in high-risk children. Halkjaer LB, Loland L, Buchvald FF, Agner T, Skov L, Strand M, Bisgaard H. Arch Dermatol; 2006 May 01; 142(5):561-6. PubMed ID: 16702493 [Abstract] [Full Text] [Related]
13. Characteristics of extrinsic vs. intrinsic atopic dermatitis in infancy: correlations with laboratory variables. Park JH, Choi YL, Namkung JH, Kim WS, Lee JH, Park HJ, Lee ES, Yang JM. Br J Dermatol; 2006 Oct 01; 155(4):778-83. PubMed ID: 16965428 [Abstract] [Full Text] [Related]
20. Eosinophil-derived neurotoxin as a biomarker for disease severity and relapse in recalcitrant atopic dermatitis. Kim HS, Kim JH, Seo YM, Chun YH, Yoon JS, Kim HH, Lee JS, Kim JT. Ann Allergy Asthma Immunol; 2017 Nov 01; 119(5):441-445. PubMed ID: 28866306 [Abstract] [Full Text] [Related] Page: [Next] [New Search]